Page 25 - TD-2-1

Tumor Discovery Cancer progression in PCOS

93. Dumesic DA, Lobo RA, 2013, Cancer risk and PCOS. https://doi.org/10.1155/2010/162363
Steroids, 78(8): 782–785. 97. Zou J, Li Y, Liao N, et al., 2022, Identification of key genes
https://doi.org/10.1016/j.steroids.2013.04.004 associated with polycystic ovary syndrome (PCOS) and
ovarian cancer using an integrated bioinformatics analysis.
94. Yumiceba V, López-Cortés A, Pérez-Villa A, et al., 2020, J Ovarian Res, 15(1): 1–16.
Oncology and pharmacogenomics insights in polycystic
ovary syndrome: An integrative analysis. Front Endocrinol https://doi.org/10.1186/s13048-022-00962-w
(Lausanne), 11: 585130. 98. Toss A, Tomasello C, Razzaboni E, et al., 2015, Hereditary
ovarian cancer: Not only BRCA 1 and 2 genes. Biomed Res
https://doi.org/10.3389/fendo.2020.585130
Int, 2015: 341723.
95. Setiawan VW, Yang HP, Pike MC, et al., 2013, Type I and II https://doi.org/10.1155/2015/341723
endometrial cancers: Have they different risk factors? Clin
Oncol, 31(20): 2607–2018. 99. Perets R, Wyant GA, Muto KW, et al., 2013, Transformation
of the fallopian tube secretory epithelium leads to high-
https://doi.org/10.1200%2FJCO.2012.48.2596 grade serous ovarian cancer in Brca; Tp53; Pten models.
96. Samarnthai N, Hall K, Yeh IT, 2010, Molecular profiling of Cancer Cell, 24(6): 751–765.
endometrial malignancies. Obstet Gynecol, 2010: 162363. https://doi.org/10.1016/j.ccr.2013.10.013

Volume 2 Issue 1 (2023) 12 https://doi.org/10.36922/td.328